These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11284463)

  • 1. Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group.
    Tfelt-Hansen P; Teall J; Rodriguez F; Giacovazzo M; Paz J; Malbecq W; Block GA; Reines SA; Visser WH
    Headache; 1998; 38(10):748-55. PubMed ID: 11284463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.
    Goldstein J; Ryan R; Jiang K; Getson A; Norman B; Block GA; Lines C
    Headache; 1998; 38(10):737-47. PubMed ID: 11284462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of preference for rizatriptan 10-mg wafer versus sumatriptan 50-mg tablet in migraine.
    Pascual J; Bussone G; Hernandez JF; Allen C; Vrijens F; Patel K;
    Eur Neurol; 2001; 45(4):275-83. PubMed ID: 11385269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral therapy for migraine: comparisons between rizatriptan and sumatriptan. A review of four randomized, double-blind clinical trials.
    Tfelt-Hansen P; Ryan RE
    Neurology; 2000; 55(9 Suppl 2):S19-24. PubMed ID: 11089515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rizatriptan: a review of its efficacy in the management of migraine.
    Dooley M; Faulds D
    Drugs; 1999 Oct; 58(4):699-723. PubMed ID: 10551439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rizatriptan and other triptans on stringent measures of efficacy.
    Adelman JU; Lipton RB; Ferrari MD; Diener HC; McCarroll KA; Vandormael K; Lines CR
    Neurology; 2001 Oct; 57(8):1377-83. PubMed ID: 11673575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of rizatriptan for the treatment of acute migraine in sumatriptan non-responders.
    Seeburger JL; Taylor FR; Friedman D; Newman L; Ge Y; Zhang Y; Hustad CM; Lasorda J; Fan X; Hewitt D; Ho T; Connor KM
    Cephalalgia; 2011 May; 31(7):786-96. PubMed ID: 21078681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
    Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
    Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.
    Visser WH; Terwindt GM; Reines SA; Jiang K; Lines CR; Ferrari MD
    Arch Neurol; 1996 Nov; 53(11):1132-7. PubMed ID: 8912486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rizatriptan 10-mg ODT for early treatment of migraine and impact of migraine education on treatment response.
    Cady RK; Martin VT; Géraud G; Rodgers A; Zhang Y; Ho AP; Hustad CM; Ho TP; Connor KM; Ramsey KE
    Headache; 2009 May; 49(5):687-96. PubMed ID: 19472447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials.
    Bussone G; D'Amico D; McCarroll KA; Gerth W; Lines CR
    Eur Neurol; 2002; 48(3):172-7. PubMed ID: 12373035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rizatriptan: pharmacological differences from sumatriptan and clinical results.
    Lines CR; McCarroll KA; Visser WH
    Curr Med Res Opin; 2001; 17 Suppl 1():s54-8. PubMed ID: 12463279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: a randomized, double-blind, placebo-controlled study.
    Winner P; Lewis D; Visser WH; Jiang K; Ahrens S; Evans JK;
    Headache; 2002 Jan; 42(1):49-55. PubMed ID: 12005275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rizatriptan: an update of its use in the management of migraine.
    Wellington K; Plosker GL
    Drugs; 2002; 62(10):1539-74. PubMed ID: 12093318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets.
    Kolodny A; Polis A; Battisti WP; Johnson-Pratt L; Skobieranda F;
    Cephalalgia; 2004 Jul; 24(7):540-6. PubMed ID: 15196296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Rizatriptan Wafer Protocol 049 Study Group.
    Ahrens SP; Farmer MV; Williams DL; Willoughby E; Jiang K; Block GA; Visser WH
    Cephalalgia; 1999 Jun; 19(5):525-30. PubMed ID: 10403069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine. Rizatriptan Multicenter Study Groups.
    Block GA; Goldstein J; Polis A; Reines SA; Smith ME
    Headache; 1998; 38(10):764-71. PubMed ID: 11284464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine.
    Bomhof M; Paz J; Legg N; Allen C; Vandormael K; Patel K
    Eur Neurol; 1999; 42(3):173-9. PubMed ID: 10529545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spotlight on rizatriptan in migraine.
    Wellington K; Jarvis B
    CNS Drugs; 2002; 16(10):715-20. PubMed ID: 12269863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.